ABSI

Absci (ABSI)

About Absci (ABSI)

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Details

Daily high

$3.60

Daily low

$3.35

Price at open

$3.37

52 Week High

$6.33

52 Week Low

$2.01

Market cap

509.8M

Dividend yield

0.00%

Volume

2.8M

Avg. volume

4.1M

P/E ratio

-3.75

Absci News